About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Role of Transposable Elements in Septic Immune Aging

NCT06809868·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Alexendar R Perez, M.D., Ph.D
CONTACT
415-476-1000 Alexendar.Perez@ucsf.edu
Matthieu Legrand, M.D., Ph.D
CONTACT
415-476-1000 matthieu.legrand@ucsf.edu

Lead

University of California, San Francisco

With

National Cancer Institute (NCI)

Age

18–any

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Age 18 or older
Admitted to ICU with sepsis (Sepsis 3 Criteria)
SOFA score of at least 2 at time of enrollment

You may not be if

Patients on organ transplantation immunosuppression
Patients with preexisting leukopenia
Cancer patients receiving CAR-T therapy
Patients who are under 18 years of age or otherwise deemed pediatric
Patients with an ongoing bleeding diathesis (ie: DIC, hemorrhagic shock)
Patients with a chronic hemoglobin below 7.0
Patients who, prior to their ICU admission, are blood transfusion dependent

The record

StatusRecruiting

PhaseNo phase

Taking part116

StartedFeb 2025

UpdatedJan 30, 2026

Conditions

Sepsis Sepsis and Septic Shock Sepsis With Multiple Organ Dysfunction (MOD)Sepsis With Acute Organ Dysfunction Sepsis, Severe+3

Where1

University of California, San Francisco
San Francisco, California, United States